Delivery Order SPE2DB22D2206-SPE2DB25FJW67
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $7,385.11. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $41,401.36, is for the supply of 120-count tablets of the cancer medication Sorafenib 200 mg. It is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2024. No set-aside designation was used for this award. In addition to this...
- The Defense Logistics Agency awarded a $8,736 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexavar 200 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,473.99 firm fixed-price delivery order is for the supply of 4,567,875,288 units of the medication Sorafenib 200 mg Tablet. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,272.22 firm fixed-price delivery order is for the provision of 120 tablets of the drug Sorafenib 200 mg. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- The Defense Logistics Agency awarded a $35,205.19 delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 25 mg capsules (28-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed and shipped...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Afinitor 10 mg tablets in unit dose packaging (28 count) with a ceiling value of $12,360.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count units) with a ceiling value of $11,228.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025, and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJW67Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $45,892.39. This firm fixed-price delivery order, awarded on September 11, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken, PA, with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company serves as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's extensive experience fulfilling competitive federal pharmaceutical contracts across multiple therapeutic domains demonstrates its capability to meet the Defense Logistics Agency's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.9k | 9/11/25 |